NM_005399.5:c.*1228G>A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005399.5(PRKAB2):​c.*1228G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.476 in 151,886 control chromosomes in the GnomAD database, including 18,336 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.48 ( 18336 hom., cov: 31)
Exomes 𝑓: 0.50 ( 0 hom. )

Consequence

PRKAB2
NM_005399.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.82

Publications

16 publications found
Variant links:
Genes affected
PRKAB2 (HGNC:9379): (protein kinase AMP-activated non-catalytic subunit beta 2) The protein encoded by this gene is a regulatory subunit of the AMP-activated protein kinase (AMPK). AMPK is a heterotrimer consisting of an alpha catalytic subunit, and non-catalytic beta and gamma subunits. AMPK is an important energy-sensing enzyme that monitors cellular energy status. In response to cellular metabolic stresses, AMPK is activated, and thus phosphorylates and inactivates acetyl-CoA carboxylase (ACC) and beta-hydroxy beta-methylglutaryl-CoA reductase (HMGCR), key enzymes involved in regulating de novo biosynthesis of fatty acid and cholesterol. This subunit may be a positive regulator of AMPK activity. It is highly expressed in skeletal muscle and thus may have tissue-specific roles. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2013]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.837 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005399.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAB2
NM_005399.5
MANE Select
c.*1228G>A
3_prime_UTR
Exon 8 of 8NP_005390.1
PRKAB2
NR_103870.2
n.1824G>A
non_coding_transcript_exon
Exon 6 of 6
PRKAB2
NR_103871.2
n.1945G>A
non_coding_transcript_exon
Exon 7 of 7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PRKAB2
ENST00000254101.4
TSL:1 MANE Select
c.*1228G>A
3_prime_UTR
Exon 8 of 8ENSP00000254101.3
PRKAB2
ENST00000896001.1
c.*1228G>A
3_prime_UTR
Exon 7 of 7ENSP00000566060.1
PRKAB2
ENST00000896002.1
c.*1228G>A
3_prime_UTR
Exon 8 of 8ENSP00000566061.1

Frequencies

GnomAD3 genomes
AF:
0.476
AC:
72174
AN:
151764
Hom.:
18307
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.578
Gnomad AMI
AF:
0.388
Gnomad AMR
AF:
0.530
Gnomad ASJ
AF:
0.360
Gnomad EAS
AF:
0.858
Gnomad SAS
AF:
0.558
Gnomad FIN
AF:
0.479
Gnomad MID
AF:
0.513
Gnomad NFE
AF:
0.373
Gnomad OTH
AF:
0.457
GnomAD4 exome
AF:
0.500
AC:
1
AN:
2
Hom.:
0
Cov.:
0
AF XY:
0.500
AC XY:
1
AN XY:
2
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AF:
0.500
AC:
1
AN:
2
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.476
AC:
72259
AN:
151884
Hom.:
18336
Cov.:
31
AF XY:
0.485
AC XY:
36014
AN XY:
74232
show subpopulations
African (AFR)
AF:
0.578
AC:
23952
AN:
41408
American (AMR)
AF:
0.531
AC:
8095
AN:
15256
Ashkenazi Jewish (ASJ)
AF:
0.360
AC:
1248
AN:
3462
East Asian (EAS)
AF:
0.858
AC:
4431
AN:
5166
South Asian (SAS)
AF:
0.557
AC:
2682
AN:
4814
European-Finnish (FIN)
AF:
0.479
AC:
5041
AN:
10522
Middle Eastern (MID)
AF:
0.527
AC:
155
AN:
294
European-Non Finnish (NFE)
AF:
0.373
AC:
25327
AN:
67942
Other (OTH)
AF:
0.462
AC:
974
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1843
3685
5528
7370
9213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
654
1308
1962
2616
3270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.415
Hom.:
29596
Bravo
AF:
0.483
Asia WGS
AF:
0.678
AC:
2358
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.74
CADD
Benign
9.0
DANN
Benign
0.74
PhyloP100
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10900321; hg19: chr1-146629916; API